# Angiotensin Receptor Blockers in Aortic Stenosis

> **NCT04913870** · PHASE4 · RECRUITING · sponsor: **Institut universitaire de cardiologie et de pneumologie de Québec, University Laval** · enrollment: 144 (estimated)

## Conditions studied

- Aortic Stenosis
- Aortic Valve Stenosis

## Interventions

- **DRUG:** Angiotensin Receptor Blockers
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04913870
- **Lead sponsor:** Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-02-01
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2024-12-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04913870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04913870, "Angiotensin Receptor Blockers in Aortic Stenosis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04913870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*